| 英文别名 |
AZ7550 Mesylate;AZ7550 trimesylate salt;2-Propenamide, N-[4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[methyl[2-(methylamino)ethyl]amino]phenyl]-;Osimertinib Impurity 31;AZ7550 salt formate;Osimertinib N desmethyl impurity 1;AZ7550;HY-B0794;CS-8145;AKOS040740713;NI2ZUZ6F4O;DTXSID301104157;AZ-7550;ZROCWKZRGJYPTG-UHFFFAOYSA-N;UNII-NI2ZUZ6F4O;1421373-99-0;AC-35817;SCHEMBL14661086;EX-A6199;N-[2-(2,5-diazahex-2-yl)-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl]prop-2-enamide;N-[4-Methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[methyl[2-(methylamino)ethyl]amino]phenyl]-2-propenamide;2-Propenamide, N-(4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-2-(methyl(2-(methylamino)ethyl)amino)phenyl)-;Osimertinib metabolite M3;BCP20939;DA-50841;BDBM50029687;N-[4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-[methyl-[2-(methylamino)ethyl]amino]phenyl]prop-2-enamide;N-(4-methoxy-2-{methyl[2-(methylamino)ethyl]amino}-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide;AZ7550; 2-Propenamide, N-[4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[methyl[2-(methylamino)ethyl]amino]phenyl]- (ACI); N-[4-Methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[methyl[2-(methylamino)ethyl]amino]phenyl]-2-propenamid;AZ 7550;N-(4-Methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-2-[methyl-(2-methylaminoethyl)amino]phenyl)prop-2-enamide;N-(4-Methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-2-(methyl(2-(methylamino)ethyl)amino)phenyl)-2-propenamide;TS-07927;CHEMBL3353412 |
